Contact

Category: Research

Research chronicles the scientific discovery, biochemical isolation, Nobel Prize-winning history, and molecular biology of Streptomyces avermitilis and macrocyclic lactone anthelmintics.

Foundational Pillars
Pharmacological Framework
Clinical Directory
Frequently Asked Questions

Foundational Clinical Pillars

Core Reference

The Longevity of Ivermectin: A Detailed Chronicle of Clinical Use Across Five Decades

Historical narrative of the Kitasato Institute soil screening and Dr. Satoshi Ōmura’s discovery.

Clinical Benchmark

How Long Has Ivermectin Been Around? A 50-Year History from 1974 to the Present

Chronological timeline of five decades of avermectin pharmaceutical evolution (1974 to present).

Safety Standard

Where Did Ivermectin Come From? The Discovery of Streptomyces avermitilis and Satoshi Ōmura

Longitudinal clinical chronicle tracing veterinary milestones and global humanitarian impacts.

Streptomyces avermitilis, Nobel Prize Recognition & Molecular Genesis

The origins of ivermectin trace back to 1974 at the Kitasato Institute in Tokyo, Japan, where microbiologist Dr. Satoshi Ōmura isolated a novel actinomycete strain from a soil sample collected near a golf course in Kawana, Shizuoka Prefecture. Dr. Ōmura cultured the organism, identifying it as a previously unknown bacterium named Streptomyces avermitilis.

Lyophilized cultures were shipped to Merck Sharp & Dohme Research Laboratories in Rahway, New Jersey, where Dr. William C. Campbell discovered that fermentation broths possessed extraordinary anthelmintic potency against nematode parasites in mice. Chemical characterization revealed a complex of eight macrocyclic lactones named avermectins. Hydrogenating avermectin B1 yielded a 80:20 mixture of 22,23-dihydroavermectin B1a and B1b—the compound named ivermectin.

Historical MilestoneYear & InstitutionScientific & Clinical Significance
Isolation of S. avermitilis1974 (Kitasato Institute)Dr. Satoshi Ōmura isolates actinomycete from Kawana soil
Discovery of Anthelmintic Efficacy1975 (Merck Labs)Dr. William C. Campbell identifies avermectin antiparasitic activity
Commercial Veterinary Launch1981 (Merck Animal Health)Ivomec introduced, revolutionizing agricultural parasitology
Nobel Prize in Medicine2015 (Karolinska Institutet)Campbell & Ōmura recognized for eradicating River Blindness

In 2015, the Nobel Assembly at Karolinska Institutet awarded the Nobel Prize in Physiology or Medicine jointly to William C. Campbell and Satoshi Ōmura ‘for their discoveries concerning a novel therapy against infections caused by roundworm parasites’. Their discovery fundamentally transformed tropical medicine and revolutionized veterinary companion animal care.

Topic Directory & Methodologies

Discovery History & Soil Actinomycetes

Nobel Recognition & Decadal Milestones

Advanced Formulations & Protocols

Frequently Asked Clinical Questions

Who discovered ivermectin and where did it come from?

It was discovered through a collaboration between Dr. Satoshi Ōmura (who isolated the bacterium Streptomyces avermitilis from a Japanese soil sample) and Dr. William C. Campbell of Merck Labs.

Why did ivermectin win the Nobel Prize in 2015?

Dr. Campbell and Dr. Ōmura shared the 2015 Nobel Prize in Medicine for developing ivermectin, which dramatically lowered the incidence of River Blindness and Lymphatic Filariasis worldwide.

What bacterium naturally produces avermectins?

Avermectins are natural fermentation products synthesized by the soil-dwelling filamentous bacterium Streptomyces avermitilis.

Notice & Clinical Safe Harbor: This educational reference is maintained by the Veterinary Parasitology & Pharmacology Standards Desk for academic, informational, and clinical research purposes. Data models published veterinary pharmacology literature, statutory veterinary monographs, and established anthelmintic posology standards. This portal does not provide certified individual veterinary medical diagnosis, prescription services, or personalized treatment regimens. For clinical diagnoses, suspected parasitic toxicosis, and individualized dosing protocols, always consult an actively licensed veterinary practitioner in your jurisdiction.

AI Editorial Policy